arrow
B

Bruce Robinson

Royal North Shore Hospital and University of Sydney
H指数:95
被引数:3.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer

2025年美国甲状腺协会成人分化型甲状腺癌管理指南

Thyroid
IF6.7
2025-08-200
PRE
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer

患者报告的Selpercatinib耐受性对比卡博赞尼/Vandetanib:一项针对RET突变髓样甲状腺癌的LIBRETTO-531随机对照试验的二次分析

Thyroid
IF6.7
2025-08-180
PRE
Increased risk of kidney failure in patients with genetic kidney disorders
2024-09-031
OAAI
Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) Network

肾小球疾病患儿及成人患者的心血管和血栓栓塞事件:Cure GlomeruloNephropathy(CureGN)网络的研究发现

2024-07-200
OA
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma

间变性甲状腺癌的基因组和进化景观

2024-03-019
OAAI
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-RefractoryDifferentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study
THYROID
IF6.7
2024-03-015
OAAI
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study

一项国际多中心研究中甲状腺髓样癌基因组谱与肿瘤特征和临床结局的关系

THYROID
IF6.7
2024-02-0119
OA
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study
2024-01-014
OAAI